David I. Rodenhiser

3.1k total citations
44 papers, 1.7k citations indexed

About

David I. Rodenhiser is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, David I. Rodenhiser has authored 44 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 17 papers in Genetics and 9 papers in Cancer Research. Recurrent topics in David I. Rodenhiser's work include Epigenetics and DNA Methylation (23 papers), Genomics and Chromatin Dynamics (9 papers) and Genetic Syndromes and Imprinting (7 papers). David I. Rodenhiser is often cited by papers focused on Epigenetics and DNA Methylation (23 papers), Genomics and Chromatin Dynamics (9 papers) and Genetic Syndromes and Imprinting (7 papers). David I. Rodenhiser collaborates with scholars based in Canada, United States and Australia. David I. Rodenhiser's co-authors include Peter Ainsworth, Bekim Sadiković, Trevor Archer, Darci T. Butcher, Shiva M. Singh, Joseph Andrews, Laila C. Schenkel, Ann F. Chambers, Erfan Aref‐Eshghi and Hanxin Lin and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Analytical Biochemistry.

In The Last Decade

David I. Rodenhiser

43 papers receiving 1.6k citations

Peers

David I. Rodenhiser
Esw Ngan Hong Kong
Liesbeth Spruijt Netherlands
H F Willard United States
Thomas Mikeska Australia
Steven E. Scherer United States
John M. Millholland United States
Esw Ngan Hong Kong
David I. Rodenhiser
Citations per year, relative to David I. Rodenhiser David I. Rodenhiser (= 1×) peers Esw Ngan

Countries citing papers authored by David I. Rodenhiser

Since Specialization
Citations

This map shows the geographic impact of David I. Rodenhiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David I. Rodenhiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David I. Rodenhiser more than expected).

Fields of papers citing papers by David I. Rodenhiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David I. Rodenhiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David I. Rodenhiser. The network helps show where David I. Rodenhiser may publish in the future.

Co-authorship network of co-authors of David I. Rodenhiser

This figure shows the co-authorship network connecting the top 25 collaborators of David I. Rodenhiser. A scholar is included among the top collaborators of David I. Rodenhiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David I. Rodenhiser. David I. Rodenhiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aref‐Eshghi, Erfan, David I. Rodenhiser, Laila C. Schenkel, et al.. (2018). Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental Syndromes. The American Journal of Human Genetics. 102(1). 156–174. 90 indexed citations
2.
Aref‐Eshghi, Erfan, Laila C. Schenkel, Peter Ainsworth, et al.. (2018). Genomic DNA Methylation-Derived Algorithm Enables Accurate Detection of Malignant Prostate Tissues. Frontiers in Oncology. 8. 100–100. 34 indexed citations
3.
Schenkel, Laila C., Erfan Aref‐Eshghi, Cindy Skinner, et al.. (2018). Peripheral blood epi-signature of Claes-Jensen syndrome enables sensitive and specific identification of patients and healthy carriers with pathogenic mutations in KDM5C. Clinical Epigenetics. 10(1). 21–21. 35 indexed citations
4.
Schenkel, Laila C., Kristin D. Kernohan, Arran McBride, et al.. (2017). Identification of epigenetic signature associated with alpha thalassemia/mental retardation X-linked syndrome. Epigenetics & Chromatin. 10(1). 10–10. 42 indexed citations
5.
Aref‐Eshghi, Erfan, Laila C. Schenkel, Hanxin Lin, et al.. (2017). Clinical Validation of a Genome-Wide DNA Methylation Assay for Molecular Diagnosis of Imprinting Disorders. Journal of Molecular Diagnostics. 19(6). 848–856. 26 indexed citations
6.
Kerkhof, Jennifer, Laila C. Schenkel, Jack Reilly, et al.. (2017). Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels. Journal of Molecular Diagnostics. 19(6). 905–920. 94 indexed citations
7.
Rodenhiser, David I., Joseph Andrews, Theodore A. Vandenberg, & Ann F. Chambers. (2011). Gene signatures of breast cancer progression and metastasis. Breast Cancer Research. 13(1). 201–201. 39 indexed citations
9.
Souter, Lesley, Joseph Andrews, Guihua Zhang, et al.. (2010). Human 21T breast epithelial cell lines mimic breast cancer progression in vivo and in vitro and show stage-specific gene expression patterns. Laboratory Investigation. 90(8). 1247–1258. 25 indexed citations
10.
Rodenhiser, David I.. (2008). Epigenetic contributions to cancer metastasis. Clinical & Experimental Metastasis. 26(1). 5–18. 32 indexed citations
11.
Rodenhiser, David I., et al.. (2008). Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays. Breast Cancer Research. 10(4). R62–R62. 56 indexed citations
12.
Goss, Paul E., Alison L. Allan, David I. Rodenhiser, Paula J. Foster, & Ann F. Chambers. (2008). New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?. Apmis. 116(7-8). 552–568. 28 indexed citations
13.
Xu, Jie, Ann F. Chambers, Alan B. Tuck, & David I. Rodenhiser. (2008). Molecular cytogenetic characterization of human breast cancer cell line MDA-MB-468 and its variant 468LN, which displays aggressive lymphatic metastasis. Cancer Genetics and Cytogenetics. 181(1). 1–7. 10 indexed citations
14.
Sadiković, Bekim, et al.. (2007). Genome-wide H3K9 Histone Acetylation Profiles Are Altered in Benzopyrene-treated MCF7 Breast Cancer Cells. Journal of Biological Chemistry. 283(7). 4051–4060. 70 indexed citations
15.
Butcher, Darci T. & David I. Rodenhiser. (2006). Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours. European Journal of Cancer. 43(1). 210–219. 77 indexed citations
16.
Butcher, Darci T., Debora Mancini‐DiNardo, Trevor Archer, & David I. Rodenhiser. (2004). DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter. International Journal of Cancer. 111(5). 669–678. 54 indexed citations
17.
Sadiković, Bekim, et al.. (2004). Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites. Breast Cancer Research. 6(4). R329–37. 29 indexed citations
18.
Butcher, Darci T., et al.. (2001). Functional analysis of CpG methylation in the BRCA1 promoter region. Oncogene. 20(38). 5331–5340. 46 indexed citations
19.
Browder, Leon W., et al.. (1992). Preparative labeling of proteins with [35S]methionine. Analytical Biochemistry. 204(1). 85–89. 6 indexed citations
20.
Rodenhiser, David I., Burr G. Atkinson, & Jack H. Jung. (1988). Synthesis and secretion of immunoglobulin G by lymphocytes from cultured mouse spleen cells is not affected by heat shock. Journal of Cellular Physiology. 135(1). 145–150. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026